Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson’s Disease Is Predominantly an Environmental Disease
E. Ray Dorsey, Bastiaan R. Bloem
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 451-465
Open Access | Times Cited: 20

Showing 20 citing articles:

Parkinson’s Disease is Predominantly a Genetic Disease
Shen‐Yang Lim, Christine Klein
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 467-482
Open Access | Times Cited: 24
Medicinal Plants with Neuroprotective Potential in East African Countries: A Systematic Review
Ibe Michael Usman, Ekom Monday Etukudo, Elna Owembabazi, et al.
Phytomedicine Plus (2025), pp. 100744-100744
Open Access | Times Cited: 1
Protecting Your Health and Brain Against Climate Change: An Information Page for Older Adults
Patricia Heyn, Elizabeth Terhune, Keshav Godha, et al.
Archives of Physical Medicine and Rehabilitation (2025)
Closed Access
Classification and Genotype–Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review
Malco Rossi, Susen Schaake, Tatiana Usnich, et al.
Movement Disorders (2025)
Open Access
Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
Shikonin Ameliorates Rotenone-Induced Neurotoxicity Through Inhibition of Apoptosis via IGF-1R/PI3K/AKT Pathway in a Parkinson’s Disease-Associated SH-SY5Y Cell Model
Aparna Anandan, Mehmet Ak, Shizuya Saika, et al.
Molecular Neurobiology (2025)
Closed Access
Nature’s Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson’s Disease
Kételin Vitória Matias, V Gonçalves, Fulvio Alexandre Scorza, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1672-1672
Open Access
The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson’s disease
Zihao Wang, Huan Xia, Tingting Feng, et al.
Neurological Sciences (2024) Vol. 45, Iss. 8, pp. 3809-3815
Closed Access | Times Cited: 4
Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications
Kajsa Brolin, Eva Schaeffer, Ashvin Kuri, et al.
Movement Disorders (2024)
Open Access | Times Cited: 3
Spatial and temporal grey water footprints of agricultural pesticide use: Improved pesticide use options to decrease water pollution in China
Jun Yi, P.W. Gerbens-Leenes, Maite M. Aldaya
Energy Nexus (2024), pp. 100349-100349
Open Access | Times Cited: 1
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”
Jolien S. Bogers, Bastiaan R. Bloem, Jonas M. den Heijer
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 2, pp. 359-360
Open Access | Times Cited: 1
Microglia: roles and genetic risk in Parkinson’s disease
A. Trainor, Debra S. MacDonald, Jay Penney
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Genome-wide association study of copy number variations in Parkinson's disease
Zied Landoulsi, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Base Hit: Neurological Diseases and Genetic Susceptibilities to Pesticide Exposures
Carrie Arnold
Environmental Health Perspectives (2024) Vol. 132, Iss. 9
Open Access
Pesticides and lifestyle factors are associated with disease severity of Parkinson's disease: a longitudinal study
Theresa Lüth, Amke Caliebe, Carolin Gabbert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Paraquat and Parkinson’s disease: has the burden of proof shifted?
Sirwan K.L. Darweesh, Roel Vermeulen, Bastiaan R. Bloem
International Journal of Epidemiology (2024) Vol. 53, Iss. 5
Closed Access
The global dimension of Parkinson's disease genetics
Thomas Gasser
The Lancet Neurology (2024)
Closed Access
Linking Environmental Genotoxins to Neurodegenerative Diseases Through Transcriptional Mutagenesis
Bert M. Verheijen, Marc Vermulst
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11429-11429
Open Access
Sex Differences in Parkinson’s Disease: A Narrative Review
C. Cattaneo, Javier Pagonabarraga
Neurology and Therapy (2024)
Open Access
The Role of ETNPPL in Dopaminergic Neuron Stability: Insights from Neuromelanin-Associated Protein Expression in Parkinson’s Disease
Francesca A. Schillaci, Giuseppe Lanza, Maria Grazia Salluzzo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13107-13107
Open Access
Parkinson’s Disease Pathogenic Variants: Cross-Ancestry Analysis and Microarray Data Validation
Samantha Hong, Mathew J. Koretsky, Jens Lichtenberg, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top